Nan Shan Life Insurance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4M Buy
+15,686
New +$15.9M 0.52% 52
2025
Q4
Sell
-21,004
Closed -$16M 93
2025
Q3
$16M Sell
21,004
-15,693
-43% -$11.7M 0.34% 70
2025
Q2
$28.6M Buy
36,697
+25,571
+230% +$19.9M 0.64% 54
2025
Q1
$9.19M Sell
11,126
-4,840
-30% -$4.03M 0.22% 82
2024
Q4
$12.3M Buy
+15,966
New +$13.2M 0.3% 78
2022
Q2
Sell
-120,174
Closed -$34.4M 92
2022
Q1
$34.4M Buy
120,174
+6,040
+5% +$1.55M 0.6% 54
2021
Q4
$31.5M Buy
114,134
+54,134
+90% +$13.7M 0.48% 65
2021
Q3
$13.9M Hold
60,000
0.23% 81
2021
Q2
$13.8M Buy
60,000
+40,000
+200% +$8.03M 0.23% 86
2021
Q1
$3.74M Buy
+20,000
New +$3.91M 0.07% 111

Other funds holding LLY

Nan Shan Life Insurance's LLY Position: Q1 2026 in Review

Nan Shan Life Insurance opened a new position in Eli Lilly (LLY) in Q1 2026: 15,686 shares worth $14.4M. The stake represents 0.52% of the portfolio and ranks #52 among its holdings. This is a return to the name: Nan Shan Life Insurance previously reported a position in LLY as recently as Q3 2025.

Nan Shan Life Insurance first reported a position in LLY in Q1 2021 and has held it in 10 quarters since. The position peaked at $34.4M in Q1 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Nan Shan Life Insurance held 15,686 shares of Eli Lilly worth $14.4M as of Q1 2026.
  • Eli Lilly was a new Nan Shan Life Insurance position in Q1 2026.
  • Eli Lilly made up 0.52% of Nan Shan Life Insurance's portfolio in Q1 2026, its #52 holding.
  • Nan Shan Life Insurance first reported a position in Eli Lilly in Q1 2021 and has held it in 10 quarters since.
  • Nan Shan Life Insurance's Eli Lilly position peaked at $34.4M in Q1 2022.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nan Shan Life Insurance's 13F filing for Q1 2026, filed 14 May 2026.